Pallasite Ventures

Ionomr Innovations Inc. is a Vancouver-based company specializing in the design, adaptation, and manufacture of advanced ion-exchange membranes and polymer technologies. Founded in 2013, Ionomr focuses on creating environmentally friendly materials that replace toxic fluorinated chemicals often used in electrochemical applications. Its flagship product line, Aemion, is designed for various applications, including water treatment, energy storage, and clean energy generation. The company’s innovative membranes are known for their alkaline stability, strength, and performance, enabling optimal integration into electrochemical systems. By providing solutions that enhance efficiency and reduce environmental impact, Ionomr aims to support the decarbonization of the planet and foster the development of sustainable systems in the renewable energy and circular chemical economies. Additionally, Ionomr offers chemical engineering services to further support its clients in achieving their operational goals.

Phoenix Molecular Designs Ltd is a biotechnology company focused on developing targeted cancer therapies, particularly small molecule kinase inhibitors. Founded in 2012 and based in Vancouver, Canada, with an additional office in San Diego, California, the company specializes in novel drugs targeting p90 ribosomal S6 kinase (RSK). This specific focus positions Phoenix Molecular Designs as a leader in utilizing RSK as a molecular target for cancer treatment, including breast cancer and Triple Negative Breast Cancer (TNBC). Their innovative platform aims to provide effective options for chemotherapy, hormone therapy, and immunotherapy, thereby addressing various oncology indications and improving outcomes for patients with refractory cancers. The company was founded by Dr. Sandra Dunn, a prominent researcher in the field of breast cancer.

Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, specializing in 3D bioprinting and tissue engineering. Founded in 2013, the company develops advanced living tissues through its proprietary microfluidic 3D bioprinting platform. This technology allows for precise control over biomaterial composition and structure during tissue fabrication, facilitating research in areas such as respiratory diseases. Aspect also provides contract testing services using its 3DAirwayALI human tissue model, catering to pharmaceutical companies and academic institutions. In addition to its core offerings, Aspect is advancing internal programs focused on regenerative medicine, particularly for metabolic diseases and musculoskeletal disorders, while collaborating with industry partners to commercialize bioprinted therapeutics.

Ionomr Innovations Inc. is a Vancouver-based company specializing in the design, adaptation, and manufacture of advanced ion-exchange membranes and polymer technologies. Founded in 2013, Ionomr focuses on creating environmentally friendly materials that replace toxic fluorinated chemicals often used in electrochemical applications. Its flagship product line, Aemion, is designed for various applications, including water treatment, energy storage, and clean energy generation. The company’s innovative membranes are known for their alkaline stability, strength, and performance, enabling optimal integration into electrochemical systems. By providing solutions that enhance efficiency and reduce environmental impact, Ionomr aims to support the decarbonization of the planet and foster the development of sustainable systems in the renewable energy and circular chemical economies. Additionally, Ionomr offers chemical engineering services to further support its clients in achieving their operational goals.

Phoenix Molecular Designs Ltd is a biotechnology company focused on developing targeted cancer therapies, particularly small molecule kinase inhibitors. Founded in 2012 and based in Vancouver, Canada, with an additional office in San Diego, California, the company specializes in novel drugs targeting p90 ribosomal S6 kinase (RSK). This specific focus positions Phoenix Molecular Designs as a leader in utilizing RSK as a molecular target for cancer treatment, including breast cancer and Triple Negative Breast Cancer (TNBC). Their innovative platform aims to provide effective options for chemotherapy, hormone therapy, and immunotherapy, thereby addressing various oncology indications and improving outcomes for patients with refractory cancers. The company was founded by Dr. Sandra Dunn, a prominent researcher in the field of breast cancer.

CTO.ai is a serverless infrastructure designed for the needs of fast moving development teams who want to measure what the business cares about. Our Commands, Pipelines, Services and Insights provide all of the tools you need to easily integrate your GitOps and ChatOps workflows, so that you can workflow smarter, not harder.

Damon is unleashing the full potential of personal mobility for the world’s commuters. With its proprietary electric drivetrain, the company has developed the world’s safest, smartest, fully connected electric motorcycle platform employing radical innovations in battery propagation resistance, sensor fusion and AI. Designed as a platform for worldwide line extension, Damon motorcycles will ship direct to consumer on subscription plans to drive scale. Based in Vancouver, Canada, Damon is a Techstars Mobility company founded by serial entrepreneurs Jay Giraud and Dom Kwong. Damon’s investors include Round 13 Capital, Techstars, Fontinalis, Extreme Venture Partners and Pallasite Ventures.

Keela provides technology solutions tailored for small and medium-sized nonprofit organizations that are often underserved by existing options. The company develops a software platform that enables nonprofits to effectively manage various aspects of their operations, including donor relations, volunteer mobilization, project management, and fundraising campaigns. By offering customizable data features, Keela's tools help organizations gain insights into their donor base, optimize campaigns, and maintain detailed donation records. The platform's design focuses on enhancing efficiency and integration of workflows, ultimately saving time and resources for these impact-driven organizations.

Phoenix Molecular Designs Ltd is a biotechnology company focused on developing targeted cancer therapies, particularly small molecule kinase inhibitors. Founded in 2012 and based in Vancouver, Canada, with an additional office in San Diego, California, the company specializes in novel drugs targeting p90 ribosomal S6 kinase (RSK). This specific focus positions Phoenix Molecular Designs as a leader in utilizing RSK as a molecular target for cancer treatment, including breast cancer and Triple Negative Breast Cancer (TNBC). Their innovative platform aims to provide effective options for chemotherapy, hormone therapy, and immunotherapy, thereby addressing various oncology indications and improving outcomes for patients with refractory cancers. The company was founded by Dr. Sandra Dunn, a prominent researcher in the field of breast cancer.

We build and maintain the website and digital marketing for your realty business, so you can stay connected with your clients—and attract new ones. As a team of marketers, engineers, and designers, we work together to give REALTORS® something they’ve never had before: The chance to market themselves online, and stand out, supported by the knowledge and tools only a team of experts can provide.

Dooly Research Ltd. is a Canadian company that specializes in developing an artificial intelligence-driven sales enablement platform designed to enhance the efficiency of sales teams. Founded in 2015, the Vancouver-based company offers software that automates the customer relationship management process by capturing, sharing, and organizing essential customer information. The platform facilitates the synchronization of digital notes, fields, and tasks directly with Salesforce, allowing sales and customer success teams to minimize time spent on administrative duties. By streamlining the flow of information from meetings and customer interactions, Dooly enables teams to focus more on closing sales and achieving core business objectives.

We build and maintain the website and digital marketing for your realty business, so you can stay connected with your clients—and attract new ones. As a team of marketers, engineers, and designers, we work together to give REALTORS® something they’ve never had before: The chance to market themselves online, and stand out, supported by the knowledge and tools only a team of experts can provide.

B2B SaaS providing market and competitive intelligence. Helps sales, and the teams that enable them, leverage competitive intelligence to win more business. It was founded in 2015 by Jason Smith and Sarathy Naicker and is headquartered in Vancouver, Canada.

Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, specializing in 3D bioprinting and tissue engineering. Founded in 2013, the company develops advanced living tissues through its proprietary microfluidic 3D bioprinting platform. This technology allows for precise control over biomaterial composition and structure during tissue fabrication, facilitating research in areas such as respiratory diseases. Aspect also provides contract testing services using its 3DAirwayALI human tissue model, catering to pharmaceutical companies and academic institutions. In addition to its core offerings, Aspect is advancing internal programs focused on regenerative medicine, particularly for metabolic diseases and musculoskeletal disorders, while collaborating with industry partners to commercialize bioprinted therapeutics.

Damon is unleashing the full potential of personal mobility for the world’s commuters. With its proprietary electric drivetrain, the company has developed the world’s safest, smartest, fully connected electric motorcycle platform employing radical innovations in battery propagation resistance, sensor fusion and AI. Designed as a platform for worldwide line extension, Damon motorcycles will ship direct to consumer on subscription plans to drive scale. Based in Vancouver, Canada, Damon is a Techstars Mobility company founded by serial entrepreneurs Jay Giraud and Dom Kwong. Damon’s investors include Round 13 Capital, Techstars, Fontinalis, Extreme Venture Partners and Pallasite Ventures.

Routific, Inc. is a Vancouver-based company that develops an advanced route optimization platform designed for delivery businesses, particularly targeting small and medium-sized enterprises in Canada and internationally. The platform features intelligent route optimization, dispatch capabilities, live tracking, and delivery notifications, which collectively help businesses reduce delivery costs, enhance driver efficiency, and improve customer satisfaction. By employing a proprietary algorithm, Routific enables last-mile delivery fleets to save up to 40% on time and fuel, establishing itself as a leading solution in the logistics sector. The company has attracted investment from notable firms including Techstars Chicago, Pallasite Ventures, Firestarter Fund, and Axiom Zen.